Short answer
Eledon Pharmaceuticals, Inc. (ELDN) filed an 8-K current report with the SEC on March 19, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Reporting of financial results for quarter and year ended December 31, 2025.
Eledon Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Reporting of financial results for quarter and year ended December 31, 2025
- Results announced via press release dated March 19, 2026, attached as Exhibit 99.1
- Press release likely contains key financial metrics and operational updates for 2025
- Important for investors tracking recent performance and outlook of Eledon Pharmaceuticals
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Eledon Pharmaceuticals, Inc. 8-K filings
Get the next ELDN 8-K as it lands
Follow ELDN for push alerts, or ask the research agent what this filing means.